⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Repertoire Immune Medicines Announces First Participant Dosed in Phase 1/2 Trial of RPTR-1-201, a T Cell-Targeted Immune Medicine for Advanced Solid Tumors
prnewswire.com
BMY
PFE
LLY
RPM
2025 Protein Synthesis Research Review and Global Market Forecasts to 2030
globenewswire.com
JAZZ
AMGN
TMO
A
ILMN
BIO
PFE
LLY
Pfizer Declares Second-Quarter 2026 Dividend
businesswire.com
PFE
Global Lung Cancer Therapeutics Market to Reach USD 142.3 Billion as Precision Medicine and Immunotherapy Redefine Oncology Care | Future Market Insights
prnewswire.com
AZN
MRK
BMY
PFE
LLY
NVS
TAK
AMGN
AI in Drug Discovery Market to Reach USD 160.49 Billion, Rising at a 23.22% CAGR by 2035
globenewswire.com
AMZN
JNJ
NVS
SNY
AZN
PFE
GSK
MRNA
BMY
LLY
MRK
ABBV
Paratus Appoints Alicia Secor as President and Chief Executive Officer; Expands Leadership Team to Support Next Phase of Growth
globenewswire.com
ZNTL
CRBU
AZN
PFE
TLRY
CATX
SYPR
SGBX
TMDX
LMT
TKO
TAK
SNY
EXAS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
accessnewswire.com
VALN
PFE
Drug Delivery Devices Market Insights, Competitive Landscape, and Forecast Report 2025-2032 - Growing Use of Biologics and Biosimilars, Technological Advancements, and Active Product Developments
globenewswire.com
PFE
JNJ
MMM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN
globenewswire.com
VALN
PFE
Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026
businesswire.com
PFE